Professor in public policy at Carleton University.
Focus on the political economy of the pharmaceutical sector.
Current research project: https://carleton.ca/ghostmanagement/
Also a big fan of craft beers, slap bass, and Japanese death metal.
Marc-André Gagnon
Loading...
www.nytimes.com/2026/05/14/o...
Fascinating read.
www.nytimes.com/interactive/...
Interesting course on Pharmaceutical Pricing Policy offered by the WHO: whoacademy.org/coursewares/...
The next Democratic president should consider who they want staffing their administration: those who will serve in government with one eye on future consulting gigs, or those for whom policy commitments come first.
prospect.org/2026/04/14/k...
Marc-André Gagnon
www.statnews.com/2026/06/09/a...
www.theguardian.com/society/2026...
Merci Radio-Canada pour votre couverture de la guerre au Liban avec des reporters locaux qui nous permettent de mieux comprendre le caractère hallucinant de la situation actuelle.
ici.radio-canada.ca/info/long-fo...
Ottawa veut pouvoir réautoriser des pesticides interdits
Avec le projet de loi C-30, le gouvernement de Mark Carney pourra invalider des décisions basées sur la science de Santé Canada au sujet des pesticides.
ici.radio-canada.ca/nouvelle/225...
@tahiramin.bsky.social and Rohit Malpani.
The innovation trap: How pharma weaponizes a word to extend monopolies
www.statnews.com/2026/05/26/h... via @statnews.com
Avec le projet de loi C-30, le gouvernement de Mark Carney pourra invalider des décisions basées sur la science de Santé Canada au sujet des pesticides.
"So anointed candidates gain money, attention, and support from a network of kingmakers and the capital that follows them, without anyone asking core questions about candidate quality or their record. "
prospect.org/2026/05/29/d...
Marc-André Gagnon
Marc-André Gagnon
Marc-André Gagnon
The detection of another circulatory system in the human body could have enormous scientific implications.
The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
Social media influencers and booming men’s health companies are pushing the hormone as an answer to all ills. But is ‘low T’ really problematic – or something created to sell men a cure to a problem t...
www.theguardian.com
Notre envoyée spéciale a parlé à des déplacés de guerre qui, dans la rue ou dans des refuges, n'ont pas accès à des installations sanitaires de base.
“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this excerpt from “Pharma Monopoly.”
